Skip to main content
. Author manuscript; available in PMC: 2024 Feb 25.
Published in final edited form as: Int J Pharm. 2023 Jan 16;633:122613. doi: 10.1016/j.ijpharm.2023.122613

Table III.

Pharmacokinetic parameters after oral gavage of LNP and NC formulation and intravenous SOL administration (n=4 rats per group, results are expressed as mean ± SD).

Cmax (ng/ml) Tmax (h) AUC0–24 (ng·h/ml) t1/2 (h) F (%)

LNP 1345.35 ± 357.86 3.13 ± 2.39 14164.44 ± 5462.42 17.29 ± 19.01 34.71 ± 12.43
NC 1018.19 ± 546.88 2.81 ± 2.67 11775.82 ± 6443.16 10.47 ± 9.45 24.46 ± 7.81
SOL 5197.97 ± 2043.49 0.12± 0.08 45790.81 ± 11459.86 3.76 ± 1.77